Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-008078
Filing Date
2023-03-17
Accepted
2023-03-17 16:05:17
Documents
5
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 formper14a.htm PRE 14A 617440
2 formper14a_001.jpg GRAPHIC 5681
3 formper14a_002.jpg GRAPHIC 40989
4 formper14a_003.jpg GRAPHIC 35896
5 formper14a_004.jpg GRAPHIC 30667
  Complete submission text file 0001493152-23-008078.txt   774913
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36357 | Film No.: 23742512
SIC: 2834 Pharmaceutical Preparations